OKYO PharmaSTU:OK10 23 FCF Yield % is -3.78 as of Jul. 03, 2026. GuruFocus rates STU:OK10 with a GF Score™ of 23/100. The stock has 3 warning signs investors should review. Among 1,413 Biotechnology companies, OKYO Pharma ranks better than 67.66% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
OKYO Pharma FCF Yield % Related Terms
OKYO Pharma FCF Yield % Historical Data
* Premium members only.
The historical data trend for OKYO Pharma's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:OK10 vs ENTX, HRTX, RANI: FCF Yield % Comparison
For the Biotechnology subindustry, OKYO Pharma's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OKYO Pharma FCF Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, OKYO Pharma's FCF Yield % distribution charts can be found below:
* The bar in red indicates where OKYO Pharma's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OKYO Pharma (STU:OK10) has a FCF Yield % of -3.78 as of Jul. 03, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on OKYO Pharma and its competitors. According to the industry distribution chart, OKYO Pharma ranks #457 out of 1413 companies in the Biotechnology industry, placing it in the top 32.3%.
Is OKYO Pharma's FCF Yield % too high?
OKYO Pharma's current FCF Yield % is -3.78. Based on the distribution chart, OKYO Pharma ranks #457 out of 1413 companies in the Biotechnology industry, which is above the industry midpoint. Overall, OKYO Pharma has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does OKYO Pharma's FCF Yield % compare to ENTX and HRTX?
According to the Biotechnology industry distribution chart, OKYO Pharma ranks #457 out of 1413 companies for FCF Yield %. This puts OKYO Pharma in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on OKYO Pharma and its competitors. OKYO Pharma's current FCF Yield % is -3.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OKYO Pharma stock overvalued right now?
OKYO Pharma (STU:OK10) has a current FCF Yield % of -3.78. The current FCF Yield % is -3.78. OKYO Pharma's overall GF Score™ is 23/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For OKYO Pharma (STU:OK10), the current FCF Yield % is -3.78 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
23GF Score
Get the complete analysis for STU:OK10
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:OK10 has been successfully added to your 
